Day 1: December 08, 2020 - In Vivo Models and Case Studies with Targeted Therapeutics Symposium Overview and Relevance to Contemporary Issues in Development of Therapeutic Agents for Oncology (Mark Merchant, Genentech) Preclinical Mouse Models for Oncology and Immuno-oncology Applications (Maryland Franklin, Covance-Preclinical Oncology) Preclinical Development of AMG 510, a First-in-human Covalent Inhibitor of KRASG12C...